<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the frequency and spectrum of mutations in the gene encoding syntaxin 11 (STX11) in <z:e sem="disease" ids="C0272199" disease_type="Neoplastic Process" abbrv="FHL|FEL|HPLH1|FHLH|HPLH|HLH1">familial haemophagocytic lymphohistiocytosis</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FHL</z:e>), a rare <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorder of <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> characterised by a defect in natural killer cell function </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Mutational analysis of STX11 by direct sequencing was done in 28 FHL families that did not harbour perforin mutations, previously identified in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FHL</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>A detailed investigation of clinical features of these patients was also undertaken </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Two different STX11 mutations were identified, one nonsense mutation and one deletion, affecting six of 34 children in four of 28 unrelated PRF1 negative families </plain></SENT>
<SENT sid="4" pm="."><plain>Both mutations have been reported before </plain></SENT>
<SENT sid="5" pm="."><plain>Three patients experienced long periods (&gt; or = 1 year) in remission without specific treatment, which is very uncommon in this disease </plain></SENT>
<SENT sid="6" pm="."><plain>Despite the milder phenotype, some children with STX11 mutations developed severe <z:hpo ids='HP_0001263'>psychomotor retardation</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Two of the six patients harbouring STX11 gene defects developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: STX11 gene mutations were found in 14% of the PRF1 negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FHL</z:e> families included in the present cohort </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that STX11 gene mutations may be associated with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and that there is segregation of specific clinical features in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FHL</z:e> patients with an underlying genotype </plain></SENT>
</text></document>